Phase 1b/2 "RAINIER" Frontline Acute Myeloid Leukemia (AML) Trial Initiated

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. SPY
2. MDT
3. DELL
4. AAPL
5. SPGI
6. USO
7. ENOV
8. PANW
9. AON
10. NIO

Go back to Phase 1b/2 "RAINIER" Frontline Acute Myeloid Leukemia (AML) Trial Initiated
(NASDAQ: APVO) Delayed: 2.34 -0.1 (4.1%)
Previous Close $2.44    52 Week High $4.33 
Open $2.44    52 Week Low $1.80 
Day High $2.44    P/E N/A 
Day Low $2.34    EPS $0.00 
Volume 31,992